MarketPulse — Real-Time Financial News & Market Analysis

Latest News

15,473 articles
Mon, Mar 9
GlobeNewswire Inc.GlobeNewswire Inc.··The Schall Law Firm

Vistagen Investors Pursue Securities Fraud Claims Over Misleading Drug Trial Statements

Schall Law Firm seeks Vistagen investors in class action over alleged false statements regarding fasedienol drug candidate's Phase 3 trial prospects.
VTGNsecurities fraudclass action lawsuit
GlobeNewswire Inc.GlobeNewswire Inc.··Na

Savage and Symbio Launch First Hydrogen Fuel Cell Drayage Truck

Savage and Symbio launch hydrogen fuel cell drayage truck with 150kW power and 34kg capacity, beginning real-world operations in zero-emission freight transport.
FAURYhydrogen storagehydrogen fuel cell
GlobeNewswire Inc.GlobeNewswire Inc.··Ninepoint Partners Lp

Ninepoint Launches Nine Single-Stock ETFs to Challenge Concentrated Bets Market

Ninepoint Partners files for nine single-stock ETFs including $NVIDIA, $TSLA, $GOOGL with competitive 0.29% fees and monthly distributions.
NVDAGOOGGOOGLPLTRTSLA+4ETFmonthly distributions
The Motley FoolThe Motley Fool··Geoffrey Seiler

GitLab Stock Plunges 60%, but Valuation Raises Buyback Questions

GitLab stock has crashed 60% following conservative fiscal 2027 guidance, but now trades at a cheap 3.7x sales multiple amid solid fundamentals.
FDSGTLBstock declineAI adoption
BenzingaBenzinga··Globe Newswire

Imperial Petroleum Declares Dividend on Series A Preferred Shares

Imperial Petroleum declares $0.546875 dividend per share on Series A preferred stock, payable March 30, 2026 to qualifying shareholders.
IMPPIMPPPdividend declarationpreferred shares
BenzingaBenzinga··Lekha Gupta

Ondas Stock Surges on Beat Results, $1.5B Cash Fuels Ambitious Growth Plan

Ondas (ONDS) shares rise after Q4 results exceed guidance, posting $29.1-$30.1M revenue with $1.5B cash and $170-$180M 2026 target.
ONDSKOMPPTFROBOrevenue guidancedefense technology
BenzingaBenzinga··Prnewswire

Antimony Emerges as Strategic Growth Play in $4B+ Critical Minerals Market

Antimony demand surges as Western nations seek domestic production alternatives to Chinese supply dominance, with market projected to grow to $4.3-4.4B by 2035.
MPLACPPTAXTPTUAMY+1critical mineralsdefense applications
The Motley FoolThe Motley Fool··John Ballard

Value Investors Bet on QuidelOrtho Turnaround as Stock Languishes

Rice Hall James increases QuidelOrtho stake to $23.8M, betting on turnaround despite stock's 43.4% annual decline.
QDELvalue investingstock purchase
BenzingaBenzinga··Akanksha Bakshi

UHS Acquires Talkspace for $835M, Doubling Down on Virtual Behavioral Health

Universal Health Services to acquire Talkspace for $5.25/share in $835M deal, expanding virtual therapy access through 6,000 licensed professionals.
UHSTALKTALKWacquisitiontelehealth
The Motley FoolThe Motley Fool··Prosper Junior Bakiny

Wood-Backed Winners: Why Robinhood and Roku Merit a Decade-Long Hold

Cathie Wood identifies Robinhood and Roku as decade-long holds, citing 52% YoY revenue growth and CTV advertising leadership respectively.
ROKUHOODrevenue growthlong-term investing
GlobeNewswire Inc.GlobeNewswire Inc.··Not Specified

OneTrust Bolsters AI Governance Platform With Real-Time Monitoring Across Enterprise Networks

OneTrust expands AI governance platform with real-time monitoring, enforcement tools. Platform adopted by Blackbaud, Kuehne + Nagel, Lumen Technologies.
LUMNBLKBKHNGYrisk managementcompliance
GlobeNewswire Inc.GlobeNewswire Inc.··Na

Junshi Biosciences Wins NMPA Nod for First Domestic Subcutaneous Anti-PD-1 Drug

Junshi Biosciences wins NMPA approval for JS001sc, first domestic subcutaneous anti-PD-1 drug across 12 indications, delivering clinical parity with IV formulation.
ENGNENGNWPhase 3 clinical trialcancer treatment
GlobeNewswire Inc.GlobeNewswire Inc.··Na

New Century Logistics Regains Nasdaq Compliance After Four-Month Battle

New Century Logistics ($NCL) restored Nasdaq compliance by maintaining $1.00+ share price for 12 consecutive days, ending non-compliance notice issued in August 2025.
NCEWlogisticsminimum bid price
GlobeNewswire Inc.GlobeNewswire Inc.··Na

Barfresh Secures $7.3M Convertible Financing to Fuel Ohio Facility Expansion

Barfresh secured $7.3M in convertible financing and $2.4M government grant to expand Ohio facility, targeting $200M+ annual capacity by fiscal 2026.
BRFHrevenue guidanceEBITDA
GlobeNewswire Inc.GlobeNewswire Inc.··Portnoy Law Firm

GoDaddy Stock Plunges 14% as Securities Investigation Looms Over Weak Guidance

GoDaddy stock fell 14% to $79.14 after disappointing Q4 results, weak 2026 guidance, and a securities fraud investigation announcement by the Portnoy Law Firm.
GDDYsecurities fraudQ4 2025 earnings
GlobeNewswire Inc.GlobeNewswire Inc.··Suzanne Mattaboni Communications

Cellhub Launches AI-Powered Virtual Care Platform to Rescue Financially Struggling Rural Hospitals

Cellhub launches AI-powered virtual care platform targeting 46% of rural hospitals operating at losses, combining 5G connectivity and managed services to address healthcare access crisis.
AAPLTMUSTMUSITMUSLTMUSZ+1telehealthcost optimization
BenzingaBenzinga··Prnewswire

Israeli AI Firm MTEK Lands Major Defense Deal for Drone Integration

Israeli AI firm Maris-Tech ($MTEK) secures major production order for Jupiter Drone system from loitering munitions manufacturer following successful pilot testing.
MTEKMTEKWdefense technologyunmanned systems
BenzingaBenzinga··Anusuya Lahiri

La Rosa Pursues Major Pivot Into AI Infrastructure Via Consensus Core Acquisition

La Rosa Holdings pivots to AI infrastructure through proposed all-equity acquisition of Nvidia Cloud Partner Consensus Core, targeting 2+ gigawatts of North American capacity.
NVDALRHCacquisitiondata center
The Motley FoolThe Motley Fool··Daniel Miller

Rivian's 2026 Comeback Hinges on R2 Launch as First Full-Year Profit Emerges

Rivian achieved 2025 gross profit of $144M despite 18% delivery decline, betting on mass-market R2 launch at $45K to drive 62K-67K units in 2026.
TSLARIVNcost reductiongross profit
BenzingaBenzinga··Prnewswire

Anixa Secures Korean Patent for Breast Cancer Vaccine, Bolstering IP Portfolio

Anixa Biosciences secures patent protection in South Korea for breast cancer vaccine technology, advancing its IP portfolio as Phase 1 trial shows 74% immune response rate.
ANIXintellectual propertyclinical trial